LGT Fund Management Co Ltd. Has $243,000 Stock Holdings in Colgate-Palmolive Company $CL

LGT Fund Management Co Ltd. decreased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 91.6% in the third quarter, Holdings Channel.com reports. The firm owned 3,070 shares of the company’s stock after selling 33,650 shares during the period. LGT Fund Management Co Ltd.’s holdings in Colgate-Palmolive were worth $243,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CL. Inceptionr LLC acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at about $628,000. Private Advisor Group LLC increased its holdings in Colgate-Palmolive by 2.4% in the third quarter. Private Advisor Group LLC now owns 79,095 shares of the company’s stock worth $6,323,000 after buying an additional 1,826 shares during the last quarter. Diversify Advisory Services LLC raised its position in Colgate-Palmolive by 33.3% during the third quarter. Diversify Advisory Services LLC now owns 17,470 shares of the company’s stock valued at $1,310,000 after acquiring an additional 4,367 shares in the last quarter. B. Metzler seel. Sohn & Co. AG raised its position in Colgate-Palmolive by 1.2% during the third quarter. B. Metzler seel. Sohn & Co. AG now owns 448,798 shares of the company’s stock valued at $35,877,000 after acquiring an additional 5,471 shares in the last quarter. Finally, Vinva Investment Management Ltd lifted its stake in Colgate-Palmolive by 27.4% in the third quarter. Vinva Investment Management Ltd now owns 114,565 shares of the company’s stock valued at $9,211,000 after acquiring an additional 24,647 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of several recent research reports. Barclays boosted their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Colgate-Palmolive from $83.00 to $90.00 and gave the company a “hold” rating in a research note on Monday, February 2nd. Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. The Goldman Sachs Group reissued a “buy” rating and set a $100.00 target price on shares of Colgate-Palmolive in a research report on Friday, February 20th. Finally, Bank of America raised their target price on Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus target price of $94.75.

Colgate-Palmolive Trading Down 0.7%

NYSE:CL opened at $92.90 on Tuesday. The company’s 50 day moving average is $89.24 and its 200-day moving average is $83.08. The company has a quick ratio of 0.54, a current ratio of 0.83 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The firm has a market cap of $74.88 billion, a price-to-earnings ratio of 35.46, a P/E/G ratio of 4.22 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The business had revenue of $5.23 billion during the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the prior year, the firm earned $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 5.8% compared to the same quarter last year. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, February 13th. Shareholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 79.39%.

Insiders Place Their Bets

In related news, insider Sally Massey sold 15,851 shares of the stock in a transaction that occurred on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total transaction of $1,506,320.53. Following the completion of the sale, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the sale, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This trade represents a 63.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 184,683 shares of company stock valued at $17,486,693. 0.41% of the stock is owned by company insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.